Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7483.074 | 0.9269 | 0.9540 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7483.074 | 0.9269 | 0.9540 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7483.074 | 1.1005 | 1.0596 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7483.074 | 1.1005 | 1.0596 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7483.074 | 0.8607 | 0.9101 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7483.074 | 0.8607 | 0.9101 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7483.074 | 0.4046 | 0.5154 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7483.074 | 0.4046 | 0.5154 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7483.074 | 0.2554 | 0.3160 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7483.074 | 0.2554 | 0.3160 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7483.074 | 0.0308 | -0.3120 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7483.074 | 0.0308 | -0.3120 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7483.074 | 0.0096 | -0.5185 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7483.074 | 0.0096 | -0.5185 | 3.2613 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7484.074 | 1.1098 | 1.0813 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7484.074 | 1.1098 | 1.0813 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7484.074 | 1.0316 | 1.0240 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7484.074 | 1.0316 | 1.0240 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7484.074 | 1.0208 | 1.0158 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7484.074 | 1.0208 | 1.0158 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7484.074 | 0.9573 | 0.9669 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7484.074 | 0.9573 | 0.9669 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7484.074 | 0.8790 | 0.9037 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7484.074 | 0.8790 | 0.9037 | 2.6137 | |
MCF 10A | NM | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7484.074 | 0.6012 | 0.6462 | 2.6137 |